Is SNWV or STIM more profitable?

Sanuwave Health has a net margin of 32.38% compared to Neuronetics' net margin of -19.62%. Sanuwave Health's return on equity of 1,728.10% beat Neuronetics' return on equity. Company Net Margins Return on Equity Return on Assets Sanuwave Health 32.38% 1,728.10% 39.04% Neuronetics -19.62% -125.11% -22.15%

Does the media refer more to SNWV or STIM?

In the previous week, Sanuwave Health had 1 more articles in the media than Neuronetics. MarketBeat recorded 3 mentions for Sanuwave Health and 2 mentions for Neuronetics. Neuronetics' average media sentiment score of 1.18 beat Sanuwave Health's score of 0.60 indicating that Neuronetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sanuwave Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Neuronetics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend INGN or SNWV?

Sanuwave Health has a consensus target price of $47.00, indicating a potential upside of 737.79%. Given Sanuwave Health's higher possible upside, analysts clearly believe Sanuwave Health is more favorable than Inogen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Sanuwave Health 2 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67

Is INGN or SNWV more profitable?

Sanuwave Health has a net margin of 32.38% compared to Inogen's net margin of -6.94%. Sanuwave Health's return on equity of 1,728.10% beat Inogen's return on equity. Company Net Margins Return on Equity Return on Assets Inogen -6.94% -13.17% -8.36% Sanuwave Health 32.38% 1,728.10% 39.04%

Does the media prefer INGN or SNWV?

In the previous week, Inogen and Inogen both had 3 articles in the media. Inogen's average media sentiment score of 0.61 beat Sanuwave Health's score of 0.60 indicating that Inogen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inogen 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sanuwave Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to FOCL or SNWV?

In the previous week, FocalTherics had 1 more articles in the media than Sanuwave Health. MarketBeat recorded 4 mentions for FocalTherics and 3 mentions for Sanuwave Health. FocalTherics' average media sentiment score of 1.22 beat Sanuwave Health's score of 0.60 indicating that FocalTherics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment FocalTherics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sanuwave Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend SNWV or ZJYL?

Sanuwave Health currently has a consensus price target of $47.00, suggesting a potential upside of 737.79%. Given Sanuwave Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Sanuwave Health is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanuwave Health 2 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, SNWV or ZJYL?

Sanuwave Health has higher revenue and earnings than Jin Medical International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sanuwave Health $44.05M 1.10 $11.81M $0.24 23.38 Jin Medical International $20.69M 16.21 $1.19M N/A N/A

Which has preferable earnings & valuation, OWLT or SNWV?

Sanuwave Health has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Owlet $105.70M 1.28 -$39.68M -$0.75 N/A Sanuwave Health $44.05M 1.10 $11.81M $0.24 23.38

Is OWLT or SNWV more profitable?

Sanuwave Health has a net margin of 32.38% compared to Owlet's net margin of -8.61%. Sanuwave Health's return on equity of 1,728.10% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets Owlet -8.61% -601.24% -15.96% Sanuwave Health 32.38% 1,728.10% 39.04%

Does the media prefer OWLT or SNWV?

In the previous week, Owlet and Owlet both had 3 articles in the media. Owlet's average media sentiment score of 1.09 beat Sanuwave Health's score of 0.60 indicating that Owlet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Owlet 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sanuwave Health 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Sanuwave Health (SNWV) Competitors

$5.33 -0.28 (-4.99%)

As of 12:05 PM Eastern

Compare

SNWV vs. STIM, INGN, FOCL, ZJYL, and OWLT

Should you buy Sanuwave Health stock or one of its competitors? Sanuwave Health's main competitors and comparable companies include Neuronetics (STIM), Inogen (INGN), FocalTherics (FOCL), Jin Medical International (ZJYL), and Owlet (OWLT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Sanuwave Health compare to Neuronetics?

Sanuwave Health (NASDAQ:SNWV) and Neuronetics (NASDAQ:STIM) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

Sanuwave Health has higher earnings, but lower revenue than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	1.10	$11.81M	$0.24	23.38
Neuronetics	$149.16M	1.02	-$39M	-$0.44	N/A

42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 53.6% of Neuronetics shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by insiders. Comparatively, 8.4% of Neuronetics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Sanuwave Health had 1 more articles in the media than Neuronetics. MarketBeat recorded 3 mentions for Sanuwave Health and 2 mentions for Neuronetics. Neuronetics' average media sentiment score of 1.18 beat Sanuwave Health's score of 0.60 indicating that Neuronetics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sanuwave Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Neuronetics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sanuwave Health presently has a consensus target price of $47.00, suggesting a potential upside of 737.79%. Neuronetics has a consensus target price of $4.67, suggesting a potential upside of 134.51%. Given Sanuwave Health's higher probable upside, equities analysts plainly believe Sanuwave Health is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Sanuwave Health has a beta of 1.42, meaning that its share price is 42% more volatile than the broader market. Comparatively, Neuronetics has a beta of 1.19, meaning that its share price is 19% more volatile than the broader market.

Sanuwave Health has a net margin of 32.38% compared to Neuronetics' net margin of -19.62%. Sanuwave Health's return on equity of 1,728.10% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	32.38%	1,728.10%	39.04%
Neuronetics	-19.62%	-125.11%	-22.15%

Summary

Sanuwave Health beats Neuronetics on 11 of the 16 factors compared between the two stocks.

How does Sanuwave Health compare to Inogen?

Inogen (NASDAQ:INGN) and Sanuwave Health (NASDAQ:SNWV) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Sanuwave Health has a consensus target price of $47.00, indicating a potential upside of 737.79%. Given Sanuwave Health's higher possible upside, analysts clearly believe Sanuwave Health is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Sanuwave Health	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

Sanuwave Health has a net margin of 32.38% compared to Inogen's net margin of -6.94%. Sanuwave Health's return on equity of 1,728.10% beat Inogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inogen	-6.94%	-13.17%	-8.36%
Sanuwave Health	32.38%	1,728.10%	39.04%

Inogen has a beta of 1.5, suggesting that its stock price is 50% more volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.42, suggesting that its stock price is 42% more volatile than the broader market.

89.9% of Inogen shares are owned by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are owned by institutional investors. 2.5% of Inogen shares are owned by company insiders. Comparatively, 14.4% of Sanuwave Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Sanuwave Health has lower revenue, but higher earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inogen	$348.67M	0.48	-$22.75M	-$0.90	N/A
Sanuwave Health	$44.05M	1.10	$11.81M	$0.24	23.38

In the previous week, Inogen and Inogen both had 3 articles in the media. Inogen's average media sentiment score of 0.61 beat Sanuwave Health's score of 0.60 indicating that Inogen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inogen	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sanuwave Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Sanuwave Health beats Inogen on 9 of the 15 factors compared between the two stocks.

How does Sanuwave Health compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and Sanuwave Health (NASDAQ:SNWV) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability, media sentiment and earnings.

Sanuwave Health has a net margin of 32.38% compared to FocalTherics' net margin of -56.26%. Sanuwave Health's return on equity of 1,728.10% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FocalTherics	-56.26%	-248.00%	-44.69%
Sanuwave Health	32.38%	1,728.10%	39.04%

FocalTherics presently has a consensus target price of $7.75, indicating a potential upside of 84.52%. Sanuwave Health has a consensus target price of $47.00, indicating a potential upside of 737.79%. Given Sanuwave Health's higher possible upside, analysts plainly believe Sanuwave Health is more favorable than FocalTherics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FocalTherics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
Sanuwave Health	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

In the previous week, FocalTherics had 1 more articles in the media than Sanuwave Health. MarketBeat recorded 4 mentions for FocalTherics and 3 mentions for Sanuwave Health. FocalTherics' average media sentiment score of 1.22 beat Sanuwave Health's score of 0.60 indicating that FocalTherics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FocalTherics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sanuwave Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sanuwave Health has lower revenue, but higher earnings than FocalTherics. FocalTherics is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FocalTherics	$70.53M	2.23	-$29.25M	-$1.03	N/A
Sanuwave Health	$44.05M	1.10	$11.81M	$0.24	23.38

FocalTherics has a beta of -0.06, suggesting that its share price is 106% less volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.42, suggesting that its share price is 42% more volatile than the broader market.

62.7% of FocalTherics shares are owned by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are owned by institutional investors. 10.1% of FocalTherics shares are owned by company insiders. Comparatively, 14.4% of Sanuwave Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Sanuwave Health beats FocalTherics on 8 of the 15 factors compared between the two stocks.

How does Sanuwave Health compare to Jin Medical International?

Sanuwave Health (NASDAQ:SNWV) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

42.5% of Sanuwave Health shares are held by institutional investors. 14.4% of Sanuwave Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Sanuwave Health currently has a consensus price target of $47.00, suggesting a potential upside of 737.79%. Given Sanuwave Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Sanuwave Health is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Sanuwave Health has higher revenue and earnings than Jin Medical International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05M	1.10	$11.81M	$0.24	23.38
Jin Medical International	$20.69M	16.21	$1.19M	N/A	N/A

Sanuwave Health has a net margin of 32.38% compared to Jin Medical International's net margin of 0.00%. Sanuwave Health's return on equity of 1,728.10% beat Jin Medical International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	32.38%	1,728.10%	39.04%
Jin Medical International	N/A	N/A	N/A

In the previous week, Sanuwave Health had 2 more articles in the media than Jin Medical International. MarketBeat recorded 3 mentions for Sanuwave Health and 1 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 1.25 beat Sanuwave Health's score of 0.60 indicating that Jin Medical International is being referred to more favorably in the news media.

Company	Overall Sentiment
Sanuwave Health	Positive
Jin Medical International	Positive

Sanuwave Health has a beta of 1.42, indicating that its share price is 42% more volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.4, indicating that its share price is 640% more volatile than the broader market.

Summary

Sanuwave Health beats Jin Medical International on 11 of the 14 factors compared between the two stocks.

How does Sanuwave Health compare to Owlet?

Owlet (NYSE:OWLT) and Sanuwave Health (NASDAQ:SNWV) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership.

72.6% of Owlet shares are held by institutional investors. Comparatively, 42.5% of Sanuwave Health shares are held by institutional investors. 36.2% of Owlet shares are held by insiders. Comparatively, 14.4% of Sanuwave Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Owlet and Owlet both had 3 articles in the media. Owlet's average media sentiment score of 1.09 beat Sanuwave Health's score of 0.60 indicating that Owlet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Owlet	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sanuwave Health	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Owlet has a beta of 1.91, suggesting that its stock price is 91% more volatile than the broader market. Comparatively, Sanuwave Health has a beta of 1.42, suggesting that its stock price is 42% more volatile than the broader market.

Owlet presently has a consensus target price of $15.00, suggesting a potential upside of 225.03%. Sanuwave Health has a consensus target price of $47.00, suggesting a potential upside of 737.79%. Given Sanuwave Health's higher possible upside, analysts plainly believe Sanuwave Health is more favorable than Owlet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Sanuwave Health	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

Sanuwave Health has a net margin of 32.38% compared to Owlet's net margin of -8.61%. Sanuwave Health's return on equity of 1,728.10% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Owlet	-8.61%	-601.24%	-15.96%
Sanuwave Health	32.38%	1,728.10%	39.04%

Sanuwave Health has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Owlet	$105.70M	1.28	-$39.68M	-$0.75	N/A
Sanuwave Health	$44.05M	1.10	$11.81M	$0.24	23.38

Summary

Owlet beats Sanuwave Health on 8 of the 15 factors compared between the two stocks.

Get Sanuwave Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNWV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SNWV vs. The Competition

Export

Metric	Sanuwave Health	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$45.63M	$5.54B	$7.28B	$13.01B
Dividend Yield	N/A	1.75%	2.51%	22.89%
P/E Ratio	22.11	25.47	275.44	25.42
Price / Sales	1.04	65.45	559.80	78.81
Price / Cash	3.44	32.25	77.16	53.04
Price / Book	28.05	5.79	10.66	5.96
Net Income	$11.81M	$146.14M	$3.50B	$380.62M
7 Day Performance	-3.79%	-2.06%	-3.65%	-3.75%
1 Month Performance	25.41%	-4.61%	-8.06%	-6.62%
1 Year Performance	-83.06%	0.59%	2.58%	-4.38%

Sanuwave Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SNWV Sanuwave Health	2.4106 of 5 stars	$5.33 -5.0%	$47.00 +781.8%	-83.2%	$45.63M	$44.05M	22.11	55	Gap Down
STIM Neuronetics	3.5562 of 5 stars	$2.16 -2.7%	$4.67 +116.0%	-27.9%	$164.59M	$149.16M	N/A	658	Positive News
INGN Inogen	1.0549 of 5 stars	$5.97 -0.2%	N/A	-21.1%	$158.43M	$354.30M	N/A	753
FOCL FocalTherics	4.4372 of 5 stars	$4.20 -2.8%	$7.75 +84.5%	N/A	$157.62M	$70.53M	N/A	230	Positive News
ZJYL Jin Medical International	1.275 of 5 stars	$1.94 -3.0%	N/A	-74.1%	$152.16M	$20.69M	N/A	273	Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SNWV) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sanuwave Health (SNWV) Competitors

SNWV vs. STIM, INGN, FOCL, ZJYL, and OWLT

How does Sanuwave Health compare to Neuronetics?

Summary

How does Sanuwave Health compare to Inogen?

Summary

How does Sanuwave Health compare to FocalTherics?

Summary

How does Sanuwave Health compare to Jin Medical International?

Summary

How does Sanuwave Health compare to Owlet?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNWV vs. The Competition

Sanuwave Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sanuwave Health (SNWV) Competitors

SNWV vs. STIM, INGN, FOCL, ZJYL, and OWLT

How does Sanuwave Health compare to Neuronetics?

Which has better valuation & earnings, SNWV or STIM?

Do insiders & institutionals hold more shares of SNWV or STIM?

Does the media refer more to SNWV or STIM?

Do analysts recommend SNWV or STIM?

Which has more risk and volatility, SNWV or STIM?

Is SNWV or STIM more profitable?

Summary

How does Sanuwave Health compare to Inogen?

Do analysts recommend INGN or SNWV?

Is INGN or SNWV more profitable?

Which has more volatility and risk, INGN or SNWV?

Do institutionals and insiders have more ownership in INGN or SNWV?

Which has preferable valuation & earnings, INGN or SNWV?

Does the media prefer INGN or SNWV?

Summary

How does Sanuwave Health compare to FocalTherics?

Is FOCL or SNWV more profitable?

Do analysts recommend FOCL or SNWV?

Does the media refer more to FOCL or SNWV?

Which has stronger valuation & earnings, FOCL or SNWV?

Which has more risk and volatility, FOCL or SNWV?

Do institutionals & insiders believe in FOCL or SNWV?

Summary

How does Sanuwave Health compare to Jin Medical International?

Do insiders and institutionals hold more shares of SNWV or ZJYL?

Do analysts recommend SNWV or ZJYL?

Which has stronger earnings and valuation, SNWV or ZJYL?

Is SNWV or ZJYL more profitable?

Does the media favor SNWV or ZJYL?

Which has more volatility & risk, SNWV or ZJYL?

Summary

How does Sanuwave Health compare to Owlet?

Do insiders & institutionals have more ownership in OWLT or SNWV?

Does the media prefer OWLT or SNWV?

Which has more risk and volatility, OWLT or SNWV?

Do analysts prefer OWLT or SNWV?

Is OWLT or SNWV more profitable?

Which has preferable earnings & valuation, OWLT or SNWV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNWV vs. The Competition

Sanuwave Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools